Detalhe da pesquisa
1.
Coagulation/fibrinolysis and circulating tumor cells in patients with advanced breast cancer.
Breast Cancer Res Treat
; 192(3): 583-591, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35132503
2.
Circulating tumor cells and survival in abiraterone- and enzalutamide-treated patients with castration-resistant prostate cancer.
Prostate
; 78(6): 435-445, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29431193
3.
Evaluation of a marker independent isolation method for circulating tumor cells in esophageal adenocarcinoma.
PLoS One
; 16(5): e0251052, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33961658
4.
Automated enumeration and phenotypic characterization of CTCs and tdEVs in patients with metastatic castration resistant prostate cancer.
Prostate Cancer Prostatic Dis
; 24(2): 499-506, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33230201
5.
TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer.
Clin Cancer Res
; 25(6): 1766-1773, 2019 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30209161
6.
Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis.
Genome Med
; 10(1): 85, 2018 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30458854